CNS Demyelinating Diseases and Pediatric Profiles
Note: No credit is offered for this program.
Overview
This session provides an in‑depth overview of evolving diagnostic approaches in neuroimmunology. Learners will explore the variability in sensitivity and specificity across assays used to detect MOG‑IgG and AQP4‑IgG, gain a clear understanding of the current diagnostic criteria for MOG‑associated disease (MOGAD), and examine the major updates introduced in the 2025 multiple sclerosis (MS) diagnostic criteria. By the end of the recording, participants will be equipped to critically evaluate assay performance, apply MOGAD diagnostic standards, and integrate the latest MS criteria into clinical practice.
Presenter
Eoin Flanagan, M.B., B.Ch.
Professor of Neurology
Department of Neurology and Department of Laboratory Medicine and Pathology
Mayo Clinic
Rochester, Minnesota
Faculty disclosure
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Questions
Contact us: mcleducation@mayo.edu
